A 52 year old man developed bulious pemphigoid, Coombs' positive haemolytic anaemia and diarrhoea related to the use of mefenamic acid. Clinical manifestation of the bulious pemphigoid, haemolytic anaemia and diarrhoea resolved following discontinuation of the mefenamic acid. Mefenamic acid should be added to the list of agents that are known to induce bulious pemphigoid.
Introduction
Drug-induced cutaneous reactions are both common and varied. Drug-induced bullous pemphigoid eruptions are rare but have been reported with the use of frusemide (Fellner & Katz, 1976; Castel et al., 1981) , psoralens (Thomsen & Schmidt, 1976) and ibuprofen (Pompeova, 1981) .
Renal impairment (Robertson et al., 1980 ) and gastrointestinal manifestations (Hall et al., 1983) have been reported frequently with the use of mefenamic acid (Ponstan). To our knowledge mefenamic acid has not been associated with the development of druginduced bullous pemphigoid. We report such a case.
Case study
In September 1983 a 52 year old man presented to the local dental hospital. Presenting symptoms were of recurrent chronic oral ulceration with watery diarrhoea, bowels opening up to six times daily. Initial investigations were unhelpful. Punch biopsy of the ulcerated tongue revealed only non-specific inflammatory changes.
By November 1983 he had deteriorated and was referred to the gastrointestinal unit for further investigation. In addition to his tongue and mouth ulceration, he had developed a non-pruritic blistering eruption with firm tense bullae up to 5cm in diameter affecting predominantly limbs and to a lesser extent trunk. Other features included watery diarrhoea with bowels opening up to 10 times daily, weight loss of 15 kg over the preceding 6 months, conjunctivitis and general malaise. Careful questioning revealed that his symptoms had started following the prescription of mefenamic acid 500 mg t.i. Medicine, 1986 manifestations of bullous pemphigoid rapidly resolved and have remained quiescent over the past 12 months. The finding of a subepidermal vesicle as well as marked IgG and C3 deposition on the basement membrane supports our diagnosis of bullous pemphigoid. Our findings are different from the cicatricial pemphigoid reported with the use of clonidine (Van Joost et al., 1980) and nadolol (Stage et al., 1984) but similar to the bullous pemphigoid noted with ibuprofen and frusemide, where the lesions healed without scarring. Our lesions were therefore consistent with the diagnosis of bullous pemphigoid. It could, however, be suggested that the introduction of mefenamic acid activated subclinical bullous pemphigoid. The reversal of other recognised drug-induced effects of mefenamic acid, particularly that of the antibodymediated Coombs' positive anaemia, would support a drug-induced effect. We feel that this drug may have induced bullous pemphigoid in our patient and that mefenamic acid should be added to the list of drugs already associated with the development of this complaint.
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